Aspen Aerogels, Inc. (NYSE:ASPN) CEO Donald R. Young Sells 256,944 Shares

Aspen Aerogels, Inc. (NYSE:ASPNGet Free Report) CEO Donald R. Young sold 256,944 shares of Aspen Aerogels stock in a transaction on Tuesday, May 28th. The shares were sold at an average price of $29.24, for a total value of $7,513,042.56. Following the completion of the sale, the chief executive officer now directly owns 502,855 shares of the company’s stock, valued at $14,703,480.20. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Aspen Aerogels Stock Up 0.9 %

Shares of NYSE ASPN opened at $29.46 on Thursday. Aspen Aerogels, Inc. has a 52-week low of $5.32 and a 52-week high of $30.28. The company has a debt-to-equity ratio of 0.24, a quick ratio of 3.29 and a current ratio of 4.01. The stock has a market cap of $2.24 billion, a P/E ratio of -66.95 and a beta of 1.97. The firm has a 50 day moving average price of $20.54 and a 200 day moving average price of $16.14.

Aspen Aerogels (NYSE:ASPNGet Free Report) last announced its quarterly earnings results on Wednesday, May 1st. The construction company reported $0.01 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.13) by $0.14. Aspen Aerogels had a negative net margin of 10.73% and a negative return on equity of 6.35%. The company had revenue of $94.50 million during the quarter, compared to analyst estimates of $73.04 million. Analysts expect that Aspen Aerogels, Inc. will post 0.08 EPS for the current year.

Hedge Funds Weigh In On Aspen Aerogels

Institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its stake in Aspen Aerogels by 5.1% in the first quarter. Vanguard Group Inc. now owns 3,619,702 shares of the construction company’s stock valued at $63,707,000 after acquiring an additional 175,906 shares during the last quarter. Hood River Capital Management LLC lifted its stake in Aspen Aerogels by 12.2% in the 1st quarter. Hood River Capital Management LLC now owns 3,300,443 shares of the construction company’s stock valued at $58,088,000 after purchasing an additional 357,895 shares during the last quarter. AIGH Capital Management LLC grew its holdings in Aspen Aerogels by 3.0% during the fourth quarter. AIGH Capital Management LLC now owns 1,804,484 shares of the construction company’s stock worth $28,475,000 after purchasing an additional 52,462 shares during the period. Federated Hermes Inc. increased its position in Aspen Aerogels by 53.9% during the fourth quarter. Federated Hermes Inc. now owns 1,154,042 shares of the construction company’s stock worth $18,211,000 after buying an additional 404,042 shares during the last quarter. Finally, UniSuper Management Pty Ltd raised its stake in Aspen Aerogels by 13.5% in the third quarter. UniSuper Management Pty Ltd now owns 1,083,836 shares of the construction company’s stock valued at $9,321,000 after buying an additional 128,974 shares during the period. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on ASPN. Roth Mkm reiterated a “buy” rating and issued a $22.00 price target on shares of Aspen Aerogels in a report on Tuesday, April 30th. HC Wainwright raised their target price on shares of Aspen Aerogels from $20.00 to $25.00 and gave the company a “buy” rating in a research note on Friday, May 3rd. TheStreet raised shares of Aspen Aerogels from a “d+” rating to a “c-” rating in a research note on Wednesday, March 6th. B. Riley raised their price objective on shares of Aspen Aerogels from $24.00 to $30.00 and gave the company a “buy” rating in a research note on Friday, May 3rd. Finally, Canaccord Genuity Group increased their price target on Aspen Aerogels from $18.00 to $28.00 and gave the company a “buy” rating in a research note on Friday, May 3rd. One investment analyst has rated the stock with a sell rating and six have given a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $26.33.

Get Our Latest Stock Report on Aspen Aerogels

Aspen Aerogels Company Profile

(Get Free Report)

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.

Read More

Insider Buying and Selling by Quarter for Aspen Aerogels (NYSE:ASPN)

Receive News & Ratings for Aspen Aerogels Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels and related companies with MarketBeat.com's FREE daily email newsletter.